A high drug failure rate is more than just a pattern recognition problem. Here's how we can address some of the root causes.
The international consulting firm Clarivate makes its bet among the novelties ready for the medicine cabinet this year: three ...
News Medical on MSN13d
Faster drug development with the help of artificial intelligenceKonstanz biologist Patrick Müller receives a Proof of Concept Grant from the European Research Council for his project "EmbryoNet-AI". Its goal is the further development of an AI-supported platform ...
The company states the acquisition will further MERIT’s service offerings, allowing for a seamless transition from ...
The Phase I study ... to propel the entire drug discovery process—from drug target discovery to efficacy evaluation—accelerating the development of groundbreaking therapies for cancer patients.” ...
Topline data on a combo including Pfizer’s kinase inhibitor Braftovi point to improved progression-free survival and pave the ...
The Phase IIa results continue a surge of momentum in a treatment space that last week saw the approval of Vertex’s Journavx ...
KORU Medical Systems (NASDAQ: KRMD) (“KORU Medical” or the “Company”), a leading medical technology company focused on the ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback